Mehmet Bakırtaş

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

End Stage Renal Disease

Multiple Myeloma

Sentinel Lymph Node

Ejection Fraction

Top Venues

Journal of chemotherapy (Florence, Italy)

Turkish journal of medical sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Mehmet Bakırtaş, Mehmet Sinan Dal, Tuğçe Nur Yiğenoğlu, Asli Odabası Giden, Istemi Serin, Semih Başcı, Yasin Kalpakci, Serdal Korkmaz, Omer Ekinci, Murat Albayrak, Abdulkadir Basturk, Duzgun Ozatli, Mehmet Hilmi Dogu, Tuba Hacıbekiroglu, Merih Kızıl Çakar, Turgay Ulas, Mine Miskioglu, Emine Gulturk, Bulent Eser, Fevzi Altuntas
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey. Journal of chemotherapy (Florence, Italy) (2023)
Hikmettullah Batgi, Başcı Semih, Mehmet Sinan Dal, Merih Kızıl Çakar, Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Nurgül Özcan, Ali Kılınç, Alparslan Merdin, Jale Yıldız, Mehmet Bakırtaş, Derya Şahin, Tahir Darçın, Dicle İskender, Nuran Ahü Baysal, Fevzi Altuntaş
Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience Turkish journal of medical sciences 51 (2) (2021)